DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 11, 2008, Pages 1270-1278

  Parsi, Mansour A ^b   Li, Ang ^a   Li, Chung Pin ^a,c   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; DNA;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BILE DUCT; BILE DUCT OBSTRUCTION; BILIARY TRACT CANCER; CONTROLLED STUDY; CYTOLOGY; DNA METHYLATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NPTX2 GENE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIMARY SCLEROSING CHOLANGITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TFPI 2 GENE;

BILE DUCT NEOPLASMS; BILE DUCTS; C-REACTIVE PROTEIN; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CYCLINS; DNA METHYLATION; GLYCOPROTEINS; HUMANS; NERVE TISSUE PROTEINS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SENSITIVITY AND SPECIFICITY;

EID: 55149093212     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.07.007     Document Type: Article

References (47)

1. Jemal A., Murray T., and Ward E. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. DeOliveira M.L., Cunningham S.C., Cameron J.L., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (2007) 755-762
3. Furukawa H., Okada S., Saisho H., et al. Clinicopathologic features of small pancreatic adenocarcinoma: a collective study. Cancer 78 (1996) 986-990
4. Cleary S.P., Gryfe R., Guindi M., et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198 (2004) 722-731
5. Agarwal B., Abu-Hamda E., Molke K.L., et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 99 (2004) 844-850
6. Harewood G.C., and Wiersema M.J. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 97 (2002) 1386-1391
7. Canto M.I., Goggins M., Hruban R.H., et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4 (2006) 766-781
8. Papachristou G.I., Smyrk T.C., and Baron T.H. Endoscopic retrograde cholangiopancreatography tissue sampling: when and how?. Clin Gastroenterol Hepatol 5 (2007) 783-790
9. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 49 (1999) 322-327
10. Kipp B.R., Stadheim L.M., Halling S.A., et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 99 (2004) 1675-1681
11. Moreno Luna L.E., Kipp B., Halling K.C., et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 131 (2006) 1064-1072
12. Barr Fritcher E.G., Kipp B.R., Slezak J.M., et al. Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy. Am J Clin Pathol 128 (2007) 272-279
13. Harewood G.C., Baron T.H., Stadheim L.M., et al. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol 99 (2004) 1464-1469
14. Lee J.G. Brush cytology and the diagnosis of pancreaticobiliary malignancy during ERCP. Gastrointest Endosc 63 (2006) 78-80
15. Maitra A., Kern S.E., and Hruban R.H. Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol 20 (2006) 211-226
16. Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol 23 (2005) 4524-4531
17. Shi C., Eshleman S.H., Jones D., et al. LigAmp for sensitive detection of single-nucleotide differences. Nat Methods 1 (2004) 141-147 Epub 2004 Oct 21
18. Iacobuzio-Donahue C.A., Ashfaq R., Maitra A., et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63 (2003) 8614-8622
19. Logsdon C.D., Simeone D.M., Binkley C., et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63 (2003) 2649-2657
20. Gronborg M., Kristiansen T.Z., Iwahori A., et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5 (2006) 157-171
21. Iacobuzio-Donahue C.A., van der Heijden M.S., Baumgartner M.R., et al. Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss. Cancer Res 64 (2004) 871-875
22. Calhoun E.S., Hucl T., Gallmeier E., et al. Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. Cancer Res 66 (2006) 7920-7928
23. Abe T., Fukushima N., Brune K., et al. Genome wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms. Clin Cancer Res 13 (2007) 6019-6025
24. Walter K., Omura N., Hong S.M., et al. Pancreatic cancer associated fibroblasts display normal allelotypes. Cancer Biol Ther 7 (2008) 882-888
25. Khalid A., Pal R., Sasatomi E., et al. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 53 (2004) 1860-1865
26. Khalid A., Nodit L., Zahid M., et al. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 101 (2006) 2493-2500
27. Matsubayashi H., Sato N., Fukushima N., et al. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 9 (2003) 1446-1452
28. Ueki T., Toyota M., Sohn T., et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60 (2000) 1835-1839
29. Sato N., Fukushima N., Maitra A., et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63 (2003) 3735-3742
30. Sato N., Matsubayashi H., Abe T., et al. Epigenetic downregulation of CDKN1C/p57KIP2 in intraductal papillary mucinous neoplasms of the pancreas by gene expression profiling. Clin Cancer Res 11 (2005) 4681-4688
31. Sato N., and Goggins M. The role of epigenetic alterations in pancreatic cancer. J Hepatobiliary Pancreat Surg 13 (2006) 286-295
32. Omura M, Li C-P, Li A, et al. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther (in press).
33. Sato N., Fukushima N., Chang R., et al. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. Gastroenterology 130 (2006) 548-565
34. Fukushima N., Walter K.M., Ueki T., et al. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther 2 (2003) 78-83
35. Matsubayashi H., Canto M., Sato N., et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 66 (2006) 1208-1217
36. Eads C.A., Danenberg K.D., Kawakami K., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28 (2000) E32
37. Matsubayashi H., Sato N., Fukushima N., et al. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 9 (2003) 1446-1452
38. Sato N., Parker A.R., Fukushima N., et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene 24 (2005) 850-858
39. Issa J.P., Ahuja N., Toyota M., et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61 (2001) 3573-3577
40. Ohuchida K., Mizumoto K., Ogura Y., et al. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 11 (2005) 2285-2292
41. Bian Y., Matsubayashi H., Pin-Li C., et al. Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs. Cancer Biol Ther 5 (2006) 1392-1399
42. Hruban R, Klein A, Eshleman J, et al. Familial pancreatic cancer. Expert Review in Gastroenterology and Hepatology (in press).
43. Klein A.P., Brune K.A., Petersen G.M., et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64 (2004) 2634-2638
44. Canto M.I., Goggins M., Yeo C.J., et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2 (2004) 606-621
45. Brentnall T.A., Bronner M.P., Byrd D.R., et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131 (1999) 247-255
46. Rajan E., Clain J.E., Levy M.J., et al. Age-related changes in the pancreas identified by EUS: a prospective evaluation. Gastrointest Endosc 61 (2005) 401-406
47. Hastier P., Buckley M.J., Dumas R., et al. A study of the effect of age on pancreatic duct morphology. Gastrointest Endosc 48 (1998) 53-57